Peering Into 2025: Will Next Year Be AI’s Huge Breakthrough Year?
With a wave of innovation having moved things forward in 2024, the AI horizon in 2025 looks bright
Read More
Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025?
What concrete strategies should employers pursue to control rising costs while ensuring the best member experience and clinical outcomes? The post Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025? appeared first on MedCity News.
KFF Health Tracking Poll: Public Views on Recent Tax and Budget Legislation
KFF’s Health Tracking Poll looks at awareness and perceived impact of the tax and budget law signed by Trump in July 2025. Nearly half of the public says that they expect the new law to generally hurt them and their families, about twice the share who say it will generally help. The law itself remains…
The Health Misinformation Monitor: Vaccine Misinformation Spreads as Children Head Back to School
This edition highlights vaccine hesitancy and misinformation around MMR (measles, mumps, and rubella) vaccines as children return to school and measles cases resurge in parts of the U.S. It also examines emerging narratives around COVID-19 vaccine misinformation following the FDA approval of COVID-19 boosters and false claims linking mpox to the vaccines.
Measles Misinformation Is on the Rise — And Americans Are Hearing It, Survey Finds
While the most serious measles epidemic in a decade has led to the deaths of two children and spread to 27 states with no signs of letting up, beliefs about the safety of the measles vaccine and the threat of the disease are sharply polarized, fed by the anti-vaccine views of the country’s seniormost health…
Syringe Exchange Fears Hobble Fight Against West Virginia HIV Outbreak
CHARLESTON, W.Va. — More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak of HIV spread mostly between people who inject opioids or methamphetamine. Infectious disease experts from the Centers for Disease Control and Prevention made a list of recommendations following their visit, including one to…
AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile. The post AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma appeared first…
Transforming Our Collective Approach to Alzheimer’s Disease Care Begins with Early and Accurate Diagnosis
While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs and symptoms of Alzheimer’s disease. The post Transforming Our Collective Approach to Alzheimer’s Disease Care Begins with Early and Accurate Diagnosis appeared first on MedCity News.
Nuclear Missile Workers Are Contracting Cancer. They Blame the Bases.
At a memorial service in 2022, veteran Air Force Capt. Monte Watts bumped into a fellow former Minuteman III nuclear missile operator, who told him that she had non-Hodgkin lymphoma. Watts knew other missileers with similar cancers. But the connection really hit home later that same January day, when the results of a blood test…
Tatiana Fofanova demos Koda Health
Tatiana Fofanova is the CEO of Koda Health. She is dealing with one of the most difficult parts of health care. How do you get patients wishes in the case of end of life or other critical illness made in advance and delivered to medical professionals? Koda Health has not only figured out how to…